Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures

NCT02957097 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02957097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02957097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Withdrawn
Start date
September 30, 2019
Completion date
July 31, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain, facial pain, pain, postoperative